Page 6 - Herpes Simplex News Today

First-in-human study aims to evaluate the safety and immunogenicity of prophylactic herpes virus vaccine candidate BNT163 BNT163 is the first candidate from BioNTech's infectious disease mRNA vaccine collaboration

Investegate announcements from BioNTech SE, BioNTech Starts Phase 1 Clinical Trial for Prophylactic Herpes Simplex Virus-2 Vaccine Candidate BNT163

UFC star Dustin Poirier is currently hospitalized with a “serious” staph (staphylococcus) infection in his left foot.

Researchers explore the anti-acne, antioxidant, and anti-inflammatory properties of Stingless bee (Tetragonula biroi)-derived propolis.

MyLAB Box has at-home tests, giving you quick, reliable test results & access to virtual medical consultations. Here MyLab Box reviews 2023.

Rutgers scientists have developed a new approach to stopping viral infections: a so-called live-attenuated, replication-defective DNA virus vaccine that uses a compound known as centanamycin to generate an altered virus for vaccine development.

Colloquially known as bodho-okhati, the false goat's beard plant grows in high altitudes, specifically of the Darjeeling Himalayan region of India and Nepal. Scientifically known as Astilbe [...]

In a recent study published in the journal Free Radical Biology and Medicine, researchers screened for neuroprotective compounds against Alzheimer’s disease (AD).

Researchers explored the impact of the coronavirus disease 2019 (COVID-19) pandemic-associated non-pharmaceutical prevention measures on the transmission of 22 infectious diseases in England.

People with a genital infection of the herpes simplex virus type 1 (HSV-1), which usually causes cold sores, frequently shed the virus in the first months after infection, raising the risk that they might spread the virus to sexual partners during this time.